Michael Moore Sells 65,000 Shares of Viemed Healthcare (NASDAQ:VMD) Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) President Michael Moore sold 65,000 shares of the business’s stock in a transaction on Friday, March 20th. The stock was sold at an average price of $8.77, for a total transaction of $570,050.00. Following the completion of the transaction, the president owned 1,585,812 shares in the company, valued at $13,907,571.24. This represents a 3.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Michael Moore also recently made the following trade(s):

• On Thursday, March 19th, Michael Moore sold 40,232 shares of Viemed Healthcare stock. The shares were sold at an average price of $9.21, for a total value of $370,536.72.
• On Wednesday, March 18th, Michael Moore sold 31,570 shares of Viemed Healthcare stock. The shares were sold at an average price of $9.42, for a total value of $297,389.40.

Viemed Healthcare Stock Down 5.5%

Shares of NASDAQ VMD opened at $8.71 on Friday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.06 and a current ratio of 1.18. Viemed Healthcare, Inc. has a 1 year low of $5.93 and a 1 year high of $10.06. The stock’s 50-day simple moving average is $8.30 and its 200-day simple moving average is $7.37. The firm has a market cap of $336.21 million, a price-to-earnings ratio of 23.54 and a beta of 1.23.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.12 by $0.02. Viemed Healthcare had a return on equity of 10.72% and a net margin of 5.53%.The firm had revenue of $76.18 million during the quarter, compared to the consensus estimate of $77.70 million.

Analysts Set New Price Targets

VMD has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Zacks Research upgraded shares of Viemed Healthcare to a “hold” rating in a research note on Thursday, January 8th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Viemed Healthcare in a report on Monday, December 29th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of “Hold”.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of VMD. Intech Investment Management LLC grew its position in shares of Viemed Healthcare by 14.4% in the 2nd quarter. Intech Investment Management LLC now owns 18,612 shares of the company’s stock worth $129,000 after acquiring an additional 2,349 shares in the last quarter. Martingale Asset Management L P raised its position in shares of Viemed Healthcare by 6.0% during the 4th quarter. Martingale Asset Management L P now owns 42,483 shares of the company’s stock valued at $316,000 after acquiring an additional 2,399 shares in the last quarter. Invesco Ltd. raised its position in shares of Viemed Healthcare by 17.1% during the 4th quarter. Invesco Ltd. now owns 21,773 shares of the company’s stock valued at $162,000 after acquiring an additional 3,173 shares in the last quarter. State of Alaska Department of Revenue bought a new position in Viemed Healthcare during the fourth quarter worth $25,000. Finally, Barclays PLC lifted its stake in Viemed Healthcare by 2.7% during the fourth quarter. Barclays PLC now owns 131,759 shares of the company’s stock worth $979,000 after purchasing an additional 3,480 shares during the last quarter. Institutional investors own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.